Want to join the conversation?
$BR said that the biggest driver of revenue and earnings growth continues to recurring revenue. The growth in recurring revenue was largely organic, with contributions from tuck-in acquisitions, mostly those closed in FY15. 2016 recurring revenue grew 9% to $1.9Bil. Revenue from closed sales accounted for 6 points of the 9% growth.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)